{{Infobox disease 
 | Name            = Pseudopseudohypoparathyroidism 
 | Image           = 
 | Caption         = 
 | DiseasesDB      = 29783 
 | ICD10           = 
 | ICD9            = {{ICD9|275.49}} 
 | ICDO            = 
 | OMIM            = 612463 
 | MedlinePlus     = 
 | eMedicineSubj   = 
 | eMedicineTopic  = 
 | MeshID          = D011556 
}}
'''Pseudopseudohypoparathyroidism''' ('''pseudoPHP''') is an inherited disorder, named for its similarity to [[pseudohypoparathyroidism]] in presentation. The term pseudopseudohypoparathyroidism is used to describe a condition where the individual has the phenotypic appearance of pseudohypoparathyroidism type 1a, but is biochemically normal.

It is sometimes considered a variant of [[Albright hereditary osteodystrophy]].<ref name="pmid1119829">{{cite journal |author=Solomon SS, Kerlan RM, King LE, Jones GM, Hashimoto K |title=Pseudopseudohypoparathyroidism with fibrous dysplasia |journal=Arch Dermatol |volume=111 |issue=1 |pages=90–3 |year=1975 |month=January |pmid=1119829 |doi= 10.1001/archderm.111.1.90|url=}}</ref>

It was characterized in 1952 by [[Fuller Albright]] as "pseudo-pseudohypoparathyroidism" (with hyphen).<ref name="BealesFarooqi2008">{{cite book|author1=Philip R. Beales|author2=I. Sadaf Farooqi|author3=Stephen O'Rahilly|title=The genetics of obesity syndromes|url=http://books.google.com/books?id=SOvEYxO2V4AC&pg=PA91|accessdate=30 October 2010|date=12 September 2008|publisher=Oxford University Press US|isbn=978-0-19-530016-1|pages=91–}}</ref><ref name="pmid13005676">{{cite journal |author=ALBRIGHT F, FORBES AP, HENNEMAN PH |title=Pseudo-pseudohypoparathyroidism |journal=Trans. Assoc. Am. Physicians |volume=65 |issue= |pages=337–50 |year=1952 |pmid=13005676 |doi= |url=}}</ref>

==Presentation==
Pseudopseudohypoparathyroidism can be best understood by comparing it to other conditions:

{| cellpadding="5" | class="wikitable"
|-
! colspan="2" | Condition
! Appearance
! [[parathyroid hormone|PTH]] levels
! [[Calcitriol]]
! [[Calcium]]
! [[Phosphates]]
! [[Genomic imprinting|Imprinting]]
|-
| colspan="2" | [[Hypoparathyroidism]]
| Normal
| Low
| Low 
| Low
| High
| Not applicable
|-
| rowspan="3" | [[Pseudohypoparathyroidism]]
| align="center" | Type 1A
| [[Albright's hereditary osteodystrophy|Skeletal defects]]
| High
| Low
| Low
| High
| Gene defect from mother ([[GNAS1]])
|-
| align="center" | Type 1B
| Normal
| High
| Low
| Low
| High
| Gene defect from mother ([[GNAS1]] and [[STX16]])
|-
| align="center" | Type 2
| Normal
| High
| Low
| Low 
| High
| ?
|-
| colspan="2" | Pseudopseudohypoparathyroidism
| [[Albright's hereditary osteodystrophy|Skeletal defects]]
| Normal
| Normal 
| Normal<ref name="HussainLatif2010">{{cite book|author1=Shahid Hussain|author2=Sharif Aaron Latif|author3=Adrian Hall|title=Rapid Review of Radiology|url=http://books.google.com/books?id=rOliqVIROGcC&pg=PA262|accessdate=30 October 2010|date=1 July 2010|publisher=Manson Publishing|isbn=978-1-84076-120-7|pages=262–}}</ref>
| Normal 
| gene defect from father
|}

Hormone resistance is not present in pseudopseudohypoparathyroidism.<ref name="pmid17803690">{{cite journal |author=Mouallem M, Shaharabany M, Weintrob N, ''et al.'' |title=Cognitive impairment is prevalent in pseudohypoparathyroidism type Ia, but not in pseudopseudohypoparathyroidism: possible cerebral imprinting of Gsalpha |journal=[[Clin. Endocrinol. (Oxf)]] |volume=68 |issue=2 |pages=233–9 |year=2008 |month=February |pmid=17803690 |doi=10.1111/j.1365-2265.2007.03025.x |url=http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=0300-0664&date=2008&volume=68&issue=2&spage=233}}</ref> [[Short stature]] may be present.<ref name="pmid9232985">{{cite journal |author=Riggs JE |title=Military service and pseudopseudohypoparathyroidism: recognizing red flags for rare medical conditions |journal=Mil Med |volume=162 |issue=7 |pages=510–2 |year=1997 |month=July |pmid=9232985 |doi= |url=}}</ref> [[Obesity]] is less common in pseudopseudohypoparathyroidism  than in pseudohypoparathyroidism.<ref name="pmid17164301">{{cite journal |author=Long DN, McGuire S, Levine MA, Weinstein LS, Germain-Lee EL |title=Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Galpha(s) in the development of human obesity |journal=J. Clin. Endocrinol. Metab. |volume=92 |issue=3 |pages=1073–9 |year=2007 |month=March |pmid=17164301 |doi=10.1210/jc.2006-1497 |url=http://jcem.endojournals.org/cgi/pmidlookup?view=long&pmid=17164301}}</ref> [[Osteoma cutis]] may be present.<ref name="pmid20523775">{{cite journal |author=Jeong KH, Lew BL, Sim WY |title=Osteoma cutis as the presenting feature of albright hereditary osteodystrophy associated with pseudopseudohypoparathyroidism |journal=Ann Dermatol |volume=21 |issue=2 |pages=154–8 |year=2009 |month=May |pmid=20523775 |pmc=2861203 |doi=10.5021/ad.2009.21.2.154 |url=http://anndermatol.org/journal/viewJournal.html?Vol=021&Num=02&page=154}}</ref>

==Inheritance==
A mother who has inherited pseudopseudohypoparathyroidism from her father may in turn pass along pseudohypoparathyroidism 1A to her children as the [[Genomic imprinting|imprinting]] pattern on the inherited paternal chromosome will be changed to the maternal pattern in the mother's ovum during meiosis.

Pseudopseudohypoparathyroidism and pseudohypoparathyroidism both involve the same [[GNAS complex locus|GNAS]] gene,<ref name="pmid20427508">{{cite journal |author=Lebrun M, Richard N, Abeguilé G, ''et al.'' |title=Progressive osseous heteroplasia: a model for the imprinting effects of GNAS inactivating mutations in humans |journal=J. Clin. Endocrinol. Metab. |volume=95 |issue=6 |pages=3028–38 |year=2010 |month=June |pmid=20427508 |doi=10.1210/jc.2009-1451 |url=http://jcem.endojournals.org/cgi/pmidlookup?view=long&pmid=20427508}}</ref> but pseudopseudohypoparathyroidism has normal calcium homeostasis because of the normal maternal allele in the [[kidney]].<ref name="TerrisGourin2008">{{cite book|author1=David Terris|author2=Christine G. Gourin|title=Thyroid and Parathyroid Diseases: Medical and Surgical Management|url=http://books.google.com/books?id=qaU-qJ5HOhsC&pg=PA193|accessdate=30 October 2010|date=15 November 2008|publisher=Thieme|isbn=978-1-58890-518-5|pages=193–}}</ref>

==Linguistic significance==
At 30 letters, the English name of the disorder is one of the candidates for being the [[longest word in English]].<ref name="urlAskOxford: What is the longest English word?">{{cite web |url=http://www.askoxford.com/asktheexperts/faq/aboutwords/longestword?view=uk |title=What is the longest English word? |work=AskOxford |publisher=Oxford Dictionaries Online |accessdate=}}</ref>

==See also==
*[[GNAS1]]
*[[Parathyroid hormone]]
*[[Longest word in English]]

==References==
{{reflist|2}}

==External links==
{{wiktionary}}

{{Endocrine pathology}}
{{Inborn errors of metal metabolism}}
{{Genomic imprinting}}
{{Deficiencies of intracellular signaling peptides and proteins}}

[[Category:Cell surface receptor deficiencies]]


{{disorder-stub}}
{{endocrine-disease-stub}}